From the FDA Blog – FDA has approved the 50th biosimilar, reflecting the markedly increased availability of biosimilar products—products that treat a wide range of chronic and severe illnesses, and which have already had an important impact on patient access!
By Patrizia Cavazzoni MD – The U.S. Food and Drug Administration regulates biological products, or biologics, which have transformed the treatment of many illnesses and are the fastest-growing class of medications in the U.S. Biologics offer hope and healing to millions of Americans, but they can be expensive.
By Patrizia Cavazzoni MD – The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research approved a wide variety of safe and effective new therapies in 2022, even as our nation continues to face the COVID-19 pandemic.
©2024 Answers Media Company, LLC